Drug interaction screens are pharmacists' responsibility

Comment

Maria Elena Alayeto. J Am Pharm Assoc (2003). 2005 Mar-Apr.

. 2005 Mar-Apr;45(2):116, 119.

doi: 10.1016/s1544-3191(15)31717-9.

No abstract available

Comment on

Drug-drug interactions: where do we go from here?
Juurlink DN. Juurlink DN. J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):128, 131-2, 134. doi: 10.1331/154434504773062573. J Am Pharm Assoc (2003). 2004. PMID: 15098846 No abstract available.
Concordance of severity ratings provided in four drug interaction compendia.
Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB. Abarca J, et al. J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):136-41. doi: 10.1331/154434504773062582. J Am Pharm Assoc (2003). 2004. PMID: 15098847
Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL, Lipton RB. Malone DC, et al. J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):142-51. doi: 10.1331/154434504773062591. J Am Pharm Assoc (2003). 2004. PMID: 15098848